Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective: Evidence From The Switch 1&2 Trials | Publicación